Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe

We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza...

Descripción completa

Detalles Bibliográficos
Autores principales: Kissling, Esther, Rondy, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322188/
https://www.ncbi.nlm.nih.gov/pubmed/28230524
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464
_version_ 1782509803050893312
author Kissling, Esther
Rondy, Marc
author_facet Kissling, Esther
Rondy, Marc
author_sort Kissling, Esther
collection PubMed
description We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65–79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).
format Online
Article
Text
id pubmed-5322188
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-53221882017-03-03 Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe Kissling, Esther Rondy, Marc Euro Surveill Rapid Communication We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65–79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2). European Centre for Disease Prevention and Control (ECDC) 2017-02-16 /pmc/articles/PMC5322188/ /pubmed/28230524 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464 Text en This article is copyright of The Authors, 2017. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Kissling, Esther
Rondy, Marc
Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
title Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
title_full Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
title_fullStr Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
title_full_unstemmed Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
title_short Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
title_sort early 2016/17 vaccine effectiveness estimates against influenza a(h3n2): i-move multicentre case control studies at primary care and hospital levels in europe
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322188/
https://www.ncbi.nlm.nih.gov/pubmed/28230524
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464
work_keys_str_mv AT kisslingesther early201617vaccineeffectivenessestimatesagainstinfluenzaah3n2imovemulticentrecasecontrolstudiesatprimarycareandhospitallevelsineurope
AT rondymarc early201617vaccineeffectivenessestimatesagainstinfluenzaah3n2imovemulticentrecasecontrolstudiesatprimarycareandhospitallevelsineurope
AT early201617vaccineeffectivenessestimatesagainstinfluenzaah3n2imovemulticentrecasecontrolstudiesatprimarycareandhospitallevelsineurope

Ejemplares similares